Lv4
530 积分 2022-02-05 加入
Lenvatinib in combination with TAS-102 for refractory metastatic colorectal cancer: A phase I/II trial
2天前
求助中
Fruquintinib in combination with sintilimab or TAS-102 as third-line or above treatment in patients with metastatic colorectal cancer: a real-world study
2天前
已完结
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study
2天前
已完结
Coronary Intravascular Lithotripsy for In-Stent Restenosis
2个月前
已完结
[Expert consensus on the application of ω-3 fatty acid prescription drugs in aging-related diseases (2024 edition)]
2个月前
已完结
[Expert consensus on the comprehensive cardiovascular risk management of hypertensive disorders in pregnancy]
2个月前
已完结
Palliative Care in Adolescents and Young Adults With Cancer
5个月前
已完结
Scotch and Pizza
5个月前
已完结
Rethinking the Functional SYNTAX Score Threshold
6个月前
已完结
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
8个月前
已完结
皖公网安备34019202002308
